A Phase 2, Multi-Dose, Double-Blind, Double-Dummy, Active-Control, Randomized Study to Evaluate the Safety, Efficacy and Pharmacokinetic Profile of Two Dosing Regimens of Zabofloxacin for the Treatment of Community-Acquired Pneumonia of Moderate Severity.

Trial Profile

A Phase 2, Multi-Dose, Double-Blind, Double-Dummy, Active-Control, Randomized Study to Evaluate the Safety, Efficacy and Pharmacokinetic Profile of Two Dosing Regimens of Zabofloxacin for the Treatment of Community-Acquired Pneumonia of Moderate Severity.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 04 May 2012

At a glance

  • Drugs Levofloxacin; Zabofloxacin
  • Indications Bacterial infections; Community-acquired pneumonia
  • Focus Adverse reactions
  • Most Recent Events

    • 04 May 2012 Actual patient number 48 added as reported by ClinicalTrials.gov.
    • 04 May 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 05 Oct 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top